1,352 results on '"Pavone, Vincenzo"'
Search Results
2. Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial
3. Designed Rubredoxin miniature in a fully artificial electron chain triggered by visible light
4. A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma
5. Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study
6. Peptide-based metalloporphyrin catalysts: unveiling the role of the metal ion in indole oxidation
7. Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
8. Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma
9. Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience
10. Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
11. Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial
12. Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
13. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
14. Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP)
15. Pharmacokinetics of the Urokinase Receptor-Derived Peptide UPARANT After Single and Multiple Doses Administration in Rats
16. COVID-19 and pneumonia: a role for the uPA/uPAR system
17. Latent Mastocytosis Triggered by COVID-19 Vaccination: A Case Report
18. Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy
19. Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
20. Conclusion
21. Bio-Identification, Value Creation and the Reproductive Bioeconomy: Insights from the Reprogenetics Sector in Spain
22. Introduction
23. Artificial Diiron Enzymes with a De Novo Designed Four‐Helix Bundle Structure
24. Selecting What? Pre-implantation Genetic Diagnosis and Screening Trajectories in Spain
25. Oocyte provision as a (quasi) social market: Insights from Spain
26. Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP)
27. Crystal structure of an amphiphilic foldamer reveals a 48-mer assembly comprising a hollow truncated octahedron.
28. Mitigation of human iris angiogenesis through uPAR/LRP-1 interaction antagonism in an organotypic ex vivo model.
29. Dye Decolorization by a Miniaturized Peroxidase Fe-MimochromeVI*a
30. UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis
31. Dye decolorization by a miniaturized peroxidase Fe-MimochromeVI*a
32. Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients
33. GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms
34. Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)
35. Diagnosis by liver stiffness measurement of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation: results from the Italian multicentric prospective study (ELASTOVOD)
36. Eggonomics: Vitrification and bioeconomies of egg donation in the United States and Spain
37. Selective Oxidation of Halophenols Catalyzed by an Artificial Miniaturized Peroxidase
38. Data from A Urokinase Receptor–Derived Peptide Inhibiting VEGF-Dependent Directional Migration and Vascular Sprouting
39. Data from UPARANT: A Urokinase Receptor–Derived Peptide Inhibitor of VEGF-Driven Angiogenesis with Enhanced Stability and In Vitro and In Vivo Potency
40. Supplementary Figure 1 from A Urokinase Receptor–Derived Peptide Inhibiting VEGF-Dependent Directional Migration and Vascular Sprouting
41. Supplementary Methods, Figure Legends, Tables 1 - 4, Figure 1 from UPARANT: A Urokinase Receptor–Derived Peptide Inhibitor of VEGF-Driven Angiogenesis with Enhanced Stability and In Vitro and In Vivo Potency
42. Preorganization of Molecular Binding Sites in Designed Diiron Proteins
43. A Systemic Approach to Security : Beyond the Tradeoff between Security and Liberty
44. Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma.
45. Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese".
46. Miniaturized Metalloproteins: Application to Iron--Sulfur Proteins
47. Retrostructural Analysis of Metalloproteins: Application to the Design of a Minimal Model for Diiron Proteins
48. Las bioeconomías de la provisión de óvulos en Estados Unidos y en España: una comparación de los mercados médicos y las implicaciones en la atención a las donantes
49. Data from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
50. Video from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.